Article
Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia.
BMC cancer - 28 Apr 2014
Farfan Mauricio J, Salas Carolina, Canales Cristina, Silva Felipe, Villarroel Milena, Kopp Katherine, Torres Juan P, Santolaya María E, Morales Jorge
Abstract excerpt
BACKGROUND: Mercaptopurine (6-MP) plays a pivotal role in treatment of childhood acute lymphoblastic leukemia (ALL); however, interindividual variability in toxicity of this drug due to genetic polymorphism in 6-MP metabolizing enzymes has been described. We determined the prevalence of the major genetic polymorphisms in 6-MP metabolizing enzymes in Chilean children with ALL. METHODS: 103 Chilean pediatric...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
